Simone M Davion

Suggest Changes
Learn More
BACKGROUND B-lymphoblastic leukemias (B-LBL) with combined IGH/BCL2 and MYC rearrangement are rare and their clinical, cytogenetic and immunophenotypic features are not well characterized. Here, we(More)
  • 1